Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-30
1993-03-23
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514929, A61K 3152
Patent
active
051964295
ABSTRACT:
A family of compounds effective in inhibiting interleukin-1 (IL-1) activity, tumor necrosis factor (TNF) activity, and the activity of other leukocyte derived cytokines is comprised of 7-(oxoalkyl) 1,3-dialkyl xanthines of the formula ##STR1## in which R.sub.1 and R.sub.2 are the same or different and are selected from the group consisting of straight-chain or branched alkyl radicals with 2 to 6 carbon atoms, cyclohexyl, alkoxyalkyl and hydroxyalkyl radicals, and A represents a hydrocarbon radical with up to 4 carbon atoms which can be substituted by a methyl group. Another family of effective compounds is identified as ##STR2## The inhibition of IL-1, TNF, and other cytokines in mammals is implicated in alleviation of a wide variety of disease conditions.
REFERENCES:
patent: 4558051 (1985-12-01), Sunshine et al.
patent: 4880791 (1989-11-01), Weithmann et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 4975432 (1990-12-01), Weithmann et al.
Avido et al., Angiology 35, 407 (1984).
Suguira et al., Japanese Journal of Anesthesiology 32, 435-41, with English translation.
Besler et al., Journal of Leukocyte Biology, 40:747-54 (1986).
Chemical Abstracts, vol. 104, No. 25, issued Jun. 23, 1986, Abstract No. 218828p.
Chemical Abstracts, vol. 101, No. 19, issued Nov. 5, 1984, Abstract No. 168805u.
John C. Robin et al., Journal of Medicine, vol. 14, No. 2, 1983, Studies on Oesteoporoses.XI--Effects of Methylxanthine Derivative, pp. 137-145.
Clinical Aspects of White Cell Rheology Reference.
Mandell Gerald L.
Novick William J.
Sullivan Gail W.
Hoechst-Roussel Pharmaceuticals Inc.
Nutter Nathan M.
University of VA Alumni Patents Foundation
LandOfFree
Method of inhibiting the activity of leukocyte derived cytokines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting the activity of leukocyte derived cytokines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting the activity of leukocyte derived cytokines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1351871